Xue Qiao Selected Research

Xue Qiao Research Topics

Disease

25	Neoplasms (Cancer) 10/2022 - 09/2011
8	Ameloblastoma 04/2022 - 01/2020
5	Inflammation (Inflammations) 06/2022 - 11/2010
3	Alcoholic Fatty Liver 06/2022 - 01/2021
2	Insulin Resistance 02/2022 - 01/2020
2	Coronary Disease (Coronary Heart Disease) 06/2021 - 11/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2019
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2021
2	Neoplasm Metastasis (Metastasis) 04/2020 - 10/2019
2	Breast Neoplasms (Breast Cancer) 10/2019 - 01/2014
2	Bacterial Infections (Bacterial Infection) 01/2019 - 12/2017
2	Sepsis (Septicemia) 01/2018 - 10/2015
2	Adenocarcinoma 01/2017 - 04/2014
2	Diarrhea 07/2016 - 01/2013
1	Glioma (Gliomas) 10/2022
1	Non-alcoholic Fatty Liver Disease 06/2022
1	Body Weight (Weight, Body) 06/2022
1	Diabetes Mellitus 02/2022
1	Cardiotoxicity 01/2022
1	COVID-19 01/2022
1	Starvation 01/2022
1	Ectropion 12/2021
1	Mouth Neoplasms (Oral Cancer) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 07/2021
1	Rare Diseases (Rare Disease) 05/2021
1	Bites and Stings (Sting) 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Peritonitis 01/2019
1	Disease Resistance 01/2019
1	Infections 01/2019

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
4	TriterpenesIBA 01/2022 - 01/2014
4	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
4	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
3	Circular RNAIBA 04/2022 - 01/2020
3	Biological ProductsIBA 05/2021 - 05/2018
3	Peptides (Polypeptides)IBA 10/2019 - 10/2015
3	CathelicidinsIBA 01/2019 - 02/2016
2	dehydroeburicoic acidIBA 06/2022 - 01/2021
2	Ethanol (Ethyl Alcohol)IBA 06/2022 - 01/2018
2	antcin KIBA 02/2022 - 07/2017
2	SaponinsIBA 01/2022 - 12/2016
2	Therapeutic UsesIBA 01/2022 - 10/2015
2	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 01/2021
2	isoangustone AIBA 07/2021 - 04/2014
2	InterferonsIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2020 - 12/2017
2	LuciferasesIBA 04/2020 - 12/2015
2	Nonprescription Drugs (Patent Medicines)IBA 11/2019 - 01/2013
2	Antimicrobial Cationic PeptidesIBA 10/2019 - 12/2017
2	AntioxidantsIBA 12/2018 - 12/2015
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2017 - 02/2016
2	gegenqinlianIBA 07/2016 - 01/2013
2	CurcuminIBA 12/2012 - 09/2011
1	Molecular Probes (Molecular Probe)IBA 10/2022
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 06/2022
1	AldehydesIBA 06/2022
1	Aldehyde DehydrogenaseIBA 06/2022
1	LipidsIBA 06/2022
1	Choline (Choline Chloride)IBA 06/2022
1	Methionine (L-Methionine)FDA Link 06/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Beclin-1IBA 01/2022
1	Drug CarriersIBA 01/2022
1	Glycyrrhetinic Acid (Po 12)IBA 01/2022
1	Annexin A5IBA 12/2021
1	PhosphatidylserinesIBA 12/2021
1	Interleukin-17 (Interleukin 17)IBA 11/2021
1	Ligases (Synthetase)IBA 10/2021
1	Tripartite Motif ProteinsIBA 10/2021
1	UbiquitinIBA 10/2021
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 06/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Lysosomal Membrane ProteinsIBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Interferon Regulatory FactorsIBA 01/2021
1	AcetaldehydeIBA 01/2021
1	Huang QiIBA 01/2021
1	Terpenes (Terpenoids)IBA 01/2021
1	LipopolysaccharidesIBA 09/2020
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 04/2020
1	Cadherins (E-Cadherin)IBA 04/2020
1	Interleukin-33IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	6-methyladenineIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	N-methyladenosineIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	danhongIBA 11/2019
1	CaspasesIBA 10/2019
1	CytokinesIBA 01/2019

Therapy/Procedure

7	Therapeutics 04/2022 - 01/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2021 - 11/2008
1	Intravenous Injections 10/2022
1	Intraperitoneal Injections 10/2022
1	Computer-Assisted Surgery (Image Guided Surgery) 10/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Conservative Treatment 01/2021